Sarcopenia and dynapenia is correlated to worse quality of life perception in middle-aged and older adults with Parkinson's disease

References

• Lee A, Gilbert RM. Epidemiology of Parkinson disease. Neurol Clin. 2016;34(4):955–65. doi:10.1016/j.ncl.2016.06.012
   PubMed Web of Science ®Google Scholar
• Butt AH, Rovini E, Dolciotti C, De Petris G, Bongioanni P, Carboncini MC, et al. Objective and automatic classification of Parkinson disease with leap motion controller. BioMed Eng OnLine. 2018;17(1):168. doi:10.1186/s12938-018-0600-7
   PubMedGoogle Scholar
• Elbaz A, Carcaillon L, Kab S, Moisan F. Epidemiology of Parkinson’s disease. Rev Neurol. 2016;172(1):14–26. doi:10.1016/j.neurol.2015.09.012
   PubMedGoogle Scholar
• Navarro-Peternella FM, Marcon SS. A convivência com a doença de Parkinson na perspectiva do parkinsoniano e seus familiares. Rev Gaúcha Enferm. 2010;31(3):415–22. Brazilian. doi:10.1590/S1983-14472010000300002
   PubMedGoogle Scholar
• Fasano A, Fung VSC, Lopiano L, Elibol B, Smolentseva IG, Seppi K, et al. Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients. BMC Neurol. 2019;19(1):50. doi:10.1186/s12883-019-1276-8
   PubMedGoogle Scholar
• Morais MB, Fracasso BM, Busnello FM, Mancopes R, Rabito EI. Doença de Parkinson em idosos: ingestão alimentar e estado nutricional. Rev Bras Geriatr Gerontol. 2013;16(3):503–11. Brazilian. doi:10.1590/S1809-98232013000300009
   Google Scholar
• Sheard JM, Ash S, Mellick GD, Silburn PA, Kerr GK. Malnutrition in a sample of community-dwelling people with Parkinson’s disease. PLoS One. 2013;8(1):e53290. doi:10.1371/journal.pone.0053290
   PubMed Web of Science ®Google Scholar
• Barichella M, Pinelli G, Iorio L, Cassani E, Valentino A, Pusani C, et al. Sarcopenia and dynapenia in patients with Parkinsonism. JAMDA. 2016;17(7):640–6. doi:10.1016/j.jamda.2016.03.016
   Web of Science ®Google Scholar
• Sheard JM, Ash S, Mellick GD, Silburn PA, Kerr GK. Improved nutritional status is related to improved quality of life in Parkinson’s disease. BMC Neurol. 2014;14(1):212. doi:10.1186/s12883-014-0212-1
   PubMedGoogle Scholar
• Ongun N. Does nutritional status affect Parkinson’s disease features and quality of life? PLoS One. 2018;13(10):e0205100. doi:10.1371/journal.pone.0205100
   PubMed Web of Science ®Google Scholar
• Mm H, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427–42.
   PubMed Web of Science ®Google Scholar
• Martínez-Martín P, Gil-Nagel A, Gracia LM, Gómez JB, Martínez-Sarriés J, Bermejo F, The Cooperative Multicentric Group. Unified Parkinson’s disease rating scale characteristics and structure. Mov Disord. 1994;9(1):76–83. doi:10.1002/mds.870090112
   PubMed Web of Science ®Google Scholar
• van Hilten JJ, van der Zwan AD, Zwinderman AH, Roos RAC. Rating impairment and disability in Parkinson’s disease: evaluation of the unified Parkinson’s disease rating scale. Mov Disord. 1994;9(1):84–88. doi:10.1002/mds.870090113
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019a;48(1):16–31. doi:10.1093/ageing/afy169
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019b;48(1):601–. doi:10.1093/ageing/afz046
   PubMed Web of Science ®Google Scholar
• Peball M, Mahlknecht P, Werkmann M, Marini K, Murr F, Herzmann H, et al. Prevalence and associated factors of sarcopenia and frailty in Parkinson’s disease: a cross-sectional study. Gerontology. 2019;65(3):216–28. doi:10.1159/000492572
   PubMed Web of Science ®Google Scholar
• Yang M, Jiang J, Zeng Y, Tang H. Sarcopenia for predicting mortality among elderly nursing home residents: SARC-F versus SARC-CalF. Medicine (Baltimore). 2019;98(7):e14546. doi:10.1097/MD.0000000000014546
   PubMed Web of Science ®Google Scholar
• Abellan VKG, Cedarbaum JM, Cesari M, Dahinden P, Fariello RG, Fielding RA, et al. Sarcopenia: biomarkers and imaging (International Conference on sarcopenia research). J Nutr Health Aging. 2011;15(10):834–46. doi:10.1007/s12603-011-0365-1
   PubMed Web of Science ®Google Scholar
• Lohman TG, Roche AF, Martorell R, editors. Anthropometric standardization reference manual. Champaign, IL: Human Kinetics Books; 1988.
   Google Scholar
• Klein S, Allison DB, Heymsfield SB, Kelley DE, Leibel RL, Nonas C, et al. Waist circumference and cardiometabolic risk: a consensus statement from Shaping America’s Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Am J Clin Nutr. 2007;85(5):1197–202. doi:10.1093/ajcn/85.5.1197
   PubMed Web of Science ®Google Scholar
• Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr. 2000;72(3):694–701. doi:10.1093/ajcn/72.3.694
   PubMed Web of Science ®Google Scholar
• Miyashita M, Narita Y, Sakamoto A, Kawada N, Akiyama M, Kayama M, et al. Health-related quality of life among community-dwelling patients with intractable neurological diseases and their caregivers in Japan: HR-QOL of intractable neurological disease. Psychiatry Clin Neurosci. 2011;65(1):30–38. doi:10.1111/j.1440-1819.2010.02155.x
   PubMed Web of Science ®Google Scholar
• Carod-Artal FJ, Vargas AP, Martinez-Martin P. Determinants of quality of life in Brazilian patients with Parkinson’s disease. Mov Disord. 2007;22(10):1408–15. doi:10.1002/mds.21408
   PubMed Web of Science ®Google Scholar
• Peto V, Jenkinson C, Fitzpatrick R. PDQ-39: a review of the development, validation and application of a Parkinson’s disease quality of life questionnaire and its associated measures. J Neuro. 1998;245(1):S10–14.
   PubMedGoogle Scholar
• Carod-Artal FJ, Martinez-Martin P, Vargas AP. Independent validation of SCOPA–psychosocial and metric properties of the PDQ-39 Brazilian version. Mov Disord. 2007;22(1):91–98. doi:10.1002/mds.21216
   PubMed Web of Science ®Google Scholar
• Tysnes OB, Storstein A. Epidemiology of Parkinson’s disease. J Neural Transm. 2017;124(8):901–5. doi:10.1007/s00702-017-1686-y
   PubMed Web of Science ®Google Scholar
• Carmo TPDSD, Ferreira CCD. Avaliação nutricional e o uso da levodopa com refeições proteicas em pacientes com doença de Parkinson do município de Macaé, Rio de Janeiro. Rev Bras Geriatr Gerontol. 2016;19:223–34. Brazilian. doi:10.1590/1809-98232016019.150141
   Google Scholar
• Hasselgren L, Olsson LL, Nyberg L. Is leg muscle strength correlated with functional balance and mobility among inpatients in geriatric rehabilitation? Arch Gerontol Geriatr. 2011;52(3):e220–25. doi:10.1016/j.archger.2010.11.016
   PubMed Web of Science ®Google Scholar
• Filippin NT, Martins JS, Dela Libera LB, Halberstadt BF, Severo AR. Qualidade de vida de sujeitos com doença de Parkinson e seus cuidadores. Fisioter mov. 2014;27(1):57–66. Brazilian. doi:10.1590/0103-5150.027.001.AO06
   Google Scholar
• Clael S, Brandão E, Caland L, Techmeier R, Paiva T, Rodrigues J, et al. Association of strength and physical functions in people with Parkinson’s disease. Neurosci J. 2018:1–5. doi:10.1155/2018/8507018
   Google Scholar
• Silva JAMG, Dibai-Filho AV, Faganello FR. Mensuração da qualidade de vida de indivíduos com a doença de Parkinson por meio do questionário PDQ-39. Fisioter mov. 2011;24(1):141–6. Brazilian. doi:10.1590/S0103-51502011000100016
   Google Scholar